Stock Earnings

Question 1

What are Castle Biosciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Castle Biosciences Inc has a total asset of $531, Net profit of $18

Question 2

What are the key financial ratios for CSTL?

Accepted Answer

Castle Biosciences Inc's Current ratio is 7.08, has a Net margin is 5.42, sales per share of $11.34.

Question 3

How is Castle Biosciences Inc's revenue broken down by segment or geography?

Accepted Answer

Castle Biosciences Inc largest revenue segment is Dermatologic, at a revenue of 256,995,999 in the most earnings release.For geography, United States is the primary market for Castle Biosciences Inc, at a revenue of 332,069,000.

Question 4

Is Castle Biosciences Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Castle Biosciences Inc has a net profit of $18

Question 5

Does Castle Biosciences Inc have any liabilities?

Accepted Answer

yes, Castle Biosciences Inc has liability of 75

Question 6

How many outstanding shares for Castle Biosciences Inc?

Accepted Answer

Castle Biosciences Inc has a total outstanding shares of 28.48

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	343	332	219	137	94	62
Revenue Growth (YoY)	10%	52%	60%	46%	52%	22%
Cost of Revenue	68	60	44	32	15	9
Gross Profit	274	271	174	105	78	53
Selling, General & Admin	220	198	178	141	86	48
Research & Development	49	51	53	44	29	13
Operating Expenses	309	263	242	196	118	59
Other Non Operating Income (Expenses)	0	--	--	--	--	0
Pretax Income	-18	21	-57	-68	-40	-10
Income Tax Expense	-6	3	0	-1	-8	0
Net Income	-12	18	-57	-67	-31	-10
Net Income Growth	-300%	-132%	-15%	115.99%	210%	-433%
Shares Outstanding (Diluted)	29.07	29.25	26.8	26.1	25.1	18.9
Shares Change (YoY)	-1%	9%	3%	4%	33%	11%
EPS (Diluted)	-0.42	0.62	-2.14	-2.58	-1.24	-0.54
EPS Growth	-310%	-129%	-17%	108%	130%	-418%
Free Cash Flow	25	36	-19	-47	-22	5
Free Cash Flow Per Share	0.85	1.23	-0.7	-1.8	-0.87	0.26
Gross Margin	79.88%	81.62%	79.45%	76.64%	82.97%	85.48%
Operating Margin	-9.91%	2.4%	-30.59%	-66.42%	-42.55%	-9.67%
Profit Margin	-3.49%	5.42%	-26.02%	-48.9%	-32.97%	-16.12%
Free Cash Flow Margin	7.28%	10.84%	-8.67%	-34.3%	-23.4%	8.06%
EBITDA	5	23	-55	-81	-37	-6
EBITDA Margin	1.45%	6.92%	-25.11%	-59.12%	-39.36%	-9.67%
D&A For EBITDA	39	15	12	10	3	0
EBIT	-34	8	-67	-91	-40	-6
EBIT Margin	-9.91%	2.4%	-30.59%	-66.42%	-42.55%	-9.67%
Effective Tax Rate	33.33%	14.28%	0%	1.47%	20%	0%

Castle Biosciences Inc (CSTL) Price

CSTL Stock Price Chart

CSTL Income

Follow-Up Questions